UCB PHARMA, S.A. secures contract for Pharmaceutical products Award of the Specific Contract for the BIMEKIZUMAB Drug derived from the Dynamic Acquisition System for the Supply of Exclusive Drugs for the Consorci Sanitari Integral

Spain, June 8 -- Spain based UCB PHARMA, S.A. has secured contract from Consorci Sanitari Integral for Pharmaceutical products Award of the Specific Contract for the BIMEKIZUMAB Drug derived from the Dynamic Acquisition System for the Supply of Exclusive Drugs for the Consorci Sanitari Integral . The value of the contract is worth 188751460 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....